LPL Financial’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Buy |
63,249
+1,214
| +2% | +$24.3K | ﹤0.01% | 3884 |
|
|
2025
Q4 | $1.01M | Sell |
62,035
-60,185
| -49% | -$909K | ﹤0.01% | 4063 |
|
|
2025
Q3 | $1.43M | Buy |
122,220
+75,275
| +160% | +$981K | ﹤0.01% | 3646 |
|
|
2025
Q2 | $544K | Buy |
46,945
+432
| +0.9% | +$3.94K | ﹤0.01% | 4307 |
|
|
2025
Q1 | $406K | Buy |
46,513
+12,742
| +38% | +$161K | ﹤0.01% | 4355 |
|
|
2024
Q4 | $485K | Buy |
33,771
+7,014
| +26% | +$111K | ﹤0.01% | 4118 |
|
|
2024
Q3 | $604K | Buy |
26,757
+8,028
| +43% | +$166K | ﹤0.01% | 3836 |
|
|
2024
Q2 | $364K | Buy |
18,729
+697
| +4% | +$18.3K | ﹤0.01% | 4115 |
|
|
2024
Q1 | $677K | Buy |
18,032
+6,859
| +61% | +$301K | ﹤0.01% | 3517 |
|
|
2023
Q4 | $625K | Buy |
11,173
+3,307
| +42% | +$144K | ﹤0.01% | 3484 |
|
|
2023
Q3 | $324K | Sell |
7,866
-5,802
| -42% | -$302K | ﹤0.01% | 3846 |
|
|
2023
Q2 | $763K | Buy |
13,668
+6,164
| +82% | +$334K | ﹤0.01% | 3087 |
|
|
2023
Q1 | $419K | Sell |
7,504
-7,856
| -51% | -$367K | ﹤0.01% | 3481 |
|
|
2022
Q4 | $560K | Sell |
15,360
-3,067
| -17% | -$100K | ﹤0.01% | 3150 |
|
|
2022
Q3 | $525K | Sell |
18,427
-3,146
| -15% | -$120K | ﹤0.01% | 3114 |
|
|
2022
Q2 | $976K | Buy |
21,573
+1,660
| +8% | +$86.1K | ﹤0.01% | 2594 |
|
|
2022
Q1 | $1.51M | Buy |
19,913
+3,611
| +22% | +$316K | ﹤0.01% | 2260 |
|
|
2021
Q4 | $2.43M | Buy |
16,302
+7,425
| +84% | +$1.14M | ﹤0.01% | 1941 |
|
|
2021
Q3 | $1.29M | Sell |
8,877
-751
| -8% | -$129K | ﹤0.01% | 2412 |
|
|
2021
Q2 | $1.89M | Buy |
9,628
+629
| +7% | +$114K | ﹤0.01% | 2035 |
|
|
2021
Q1 | $1.63M | Buy |
8,999
+1,972
| +28% | +$341K | ﹤0.01% | 1996 |
|
|
2020
Q4 | $995K | Buy |
7,027
+3,503
| +99% | +$508K | ﹤0.01% | 2187 |
|
|
2020
Q3 | $439K | Buy |
+3,524
| New | +$370K | ﹤0.01% | 2578 |
|
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
